This compound is a Boc-protected pharmaceutical intermediate featuring a purine core linked to a piperidine ring and a quinazoline group. It is primarily used in the synthesis of more complex active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 668273-75-4
Tert-butyl 4H,5H,6H,7H-thieno[3,2-c]pyridine-5-carboxylate
Boc-protected pharmaceutical intermediate
(S)-tert-Butyl (1-oxo-1-phenylhex-5-yn-2-yl)carbamate
Boc-protected pharmaceutical intermediate
2-chloropyridine-3-sulfonyl Chloride
Pharmaceutical intermediate for sulfonamide synthesis
Alpha-keto-beta-methylvaleric acid, calcium salt
branched-chain keto acid calcium salt
1-methylcyclopropane-1-sulfonamide
pharmaceutical intermediate
2-Chloro-5-methylnicotinic acid
Pharmaceutical intermediate for drug synthesis
LINAGLIPTIN, (S)-
active pharmaceutical ingredient
Linagliptine
active pharmaceutical ingredient
tert-butyl N-[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]carbamate
PQEIZFATTRGTNW-HXUWFJFHSA-N
CC#CCN1C2=C(N=C1N3CCC[C@H](C3)NC(=O)OC(C)(C)C)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C